By additional molecular analyses, BRAF and FGFR1 gene alterations specific to each subgroup were identified: particularly, BRAF alterations in the astrocytic-like group 1 and FGFR1 alterations in group 2, oligodendroglial tumors [139]. This evidence concerns the gene BRAF and oligodendroglial tumor.